All posts tagged Robert Doebele

  • Promising phase 1/2 results for entrectinib against ROS1+ non-small cell lung cancer

    We are hopeful that entrectinib will help us control many cases of ROS1+ lung cancer in both the body and the brain,” says Robert C. Doebele, MD, PhD.